Tuesday, July 21, 2026

#FDA regulation

3 articles

FDA Warning Letter Hits Kestra Rival, Raising Scrutiny Risk for ASSURE Defibrillator

Regulatory Risk & Corporate Strategy

FDA Warning Letter Hits Kestra Rival, Raising Scrutiny Risk for ASSURE Defibrillator

Salvado•Jul 17, 2026

AI Virtual Twins Hit 2,000 Medical Procedures as FDA Guidelines Enable Drug Trial Shortcuts

Healthcare Investment

AI Virtual Twins Hit 2,000 Medical Procedures as FDA Guidelines Enable Drug Trial Shortcuts

Salvado•Mar 21, 2026

FDA Compounding Crackdown Threatens TomorrowsRx Core Revenue as GLP-1 Shortages End

Healthcare Finance

FDA Compounding Crackdown Threatens TomorrowsRx Core Revenue as GLP-1 Shortages End

ViaNews Editorial Team (Finance)•Feb 21, 2026